In this volume 8 of the Cardiovascular Genomics Insights, we discuss the role of genetics in the management of ARVC patients, with the contribution of Professor Kristina Haugaa. This content highlights the impact of the 2023 ESC Guidelines on cardiomyopathy on the care of patients, including children.
The importance of the new ESC guidelines for the management of cardiomyopathies in non-dilated left ventricular cardiomy
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy (ARVC)
How to article: Prescribe Exercise in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy
ARVC Quiz based on the 2023 ESC Guidelines for Cardiomyopathies
Discussions about genetics in ARVC